099430 — Bio Plus Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Bio Plus Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	37,418	56,719	65,043	66,410	90,896
Cost of Revenue
Gross Profit	23,646	33,806	39,573	42,643	60,608
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	20,756	31,475	37,008	42,742	75,987
Operating Profit	16,662	25,243	28,035	23,667	14,909
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	14,168	27,471	32,740	17,664	17,536
Provision for Income Taxes
Net Income After Taxes	10,673	20,708	27,422	17,510	19,996
Minority Interest
Net Income Before Extraordinary Items
Net Income	10,673	21,137	25,581	14,151	15,001
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	10,673	21,137	26,258	14,919	10,228
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	229	370	433	237	150
Dividends per Share